Alzheimer Europe renews its membership of European Medicines' Agency Patients' and Consumers' Working Party for the term 2022 to 2025


On 28 April 2022, the European Medicines' Agency (EMA) notified Alzheimer Europe that its membership to the Patients' and Consumers' Working Party (PCWP) had been successfully renewed. The PCWP provides a platform for exchange of information and discussion of issues of common interest between the EMA and patients and consumers. Established in 2006, it has enabled the Agency to build upon its existing interactions with patients and consumers. It provides recommendations to the EMA and its human scientific committees on all matters of interest in relation to medicines. Find out more about the PCWP and about the process of becoming a member as outlined in its mandate, on the working party's webpage:

Alzheimer Europe has nominated Angela Bradshaw, Project Officer as its member of the PCWP and Cindy Birck, Project Officer as its alternate.